These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 1348295)

  • 1. Autoantibody against oxidised LDL and progression of carotid atherosclerosis.
    Salonen JT; Ylä-Herttuala S; Yamamoto R; Butler S; Korpela H; Salonen R; Nyyssönen K; Palinski W; Witztum JL
    Lancet; 1992 Apr; 339(8798):883-7. PubMed ID: 1348295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
    Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G
    J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. A case-control study. The ARIC Study Investigators. Atherosclerosis Risk in Communities.
    Iribarren C; Folsom AR; Jacobs DR; Gross MD; Belcher JD; Eckfeldt JH
    Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1171-7. PubMed ID: 9194770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis.
    Karvonen J; Päivänsalo M; Kesäniemi YA; Hörkkö S
    Circulation; 2003 Oct; 108(17):2107-12. PubMed ID: 14530200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus.
    Uusitupa MI; Niskanen L; Luoma J; Vilja P; Mercuri M; Rauramaa R; Ylä-Herttuala S
    Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1236-42. PubMed ID: 8857919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes.
    Freigang S; Hörkkö S; Miller E; Witztum JL; Palinski W
    Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1972-82. PubMed ID: 9848892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM.
    Bellomo G; Maggi E; Poli M; Agosta FG; Bollati P; Finardi G
    Diabetes; 1995 Jan; 44(1):60-6. PubMed ID: 7813815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carotid intima-media thickening and in vivo LDL oxidation in patients with essential hypertension.
    Marchesi E; Martignoni A; Salvini M; Catalano O; Maggi E; Negro C; Traversa B; Bellomo G
    J Hum Hypertens; 1996 Sep; 10(9):577-82. PubMed ID: 8953201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers.
    Maggi E; Chiesa R; Melissano G; Castellano R; Astore D; Grossi A; Finardi G; Bellomo G
    Arterioscler Thromb; 1994 Dec; 14(12):1892-9. PubMed ID: 7981176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of autoantibodies against oxidatively modified low density lipoproteins during long-term LDL-apheresis.
    Turk Z; Mrzljak V; Turk N; Metelko Z
    Diabetes Nutr Metab; 1999 Dec; 12(6):413-7. PubMed ID: 10782563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies against oxidatively modified LDL do not constitute a risk factor for stroke: a nested case-control study.
    Ahmed E; Trifunovic J; Stegmayr B; Hallmans G; Lefvert AK
    Stroke; 1999 Dec; 30(12):2541-6. PubMed ID: 10582975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against oxidised low-density lipoprotein in hypopituitary patients with growth hormone deficiency.
    Ozbey N; Aydin A; Telci A; Cakatay U
    Endocr J; 2001 Oct; 48(5):579-84. PubMed ID: 11789563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls.
    van de Vijver LP; Steyger R; van Poppel G; Boer JM; Kruijssen DA; Seidell JC; Princen HM
    Atherosclerosis; 1996 May; 122(2):245-53. PubMed ID: 8769687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
    McDowell A; Young IS; Wisdom GB
    J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoantibodies against oxidised low density lipoproteins in patients with coronary disease].
    Maggi E; Perani G; Falaschi F; Frattoni A; Martignoni A; Finardi G; Stefano PL; Simeone F; Paolini G; DeVecchi E
    Presse Med; 1994 Jul 2-9; 23(25):1158-62. PubMed ID: 7971845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies against modified low-density lipoproteins in coronary artery disease.
    Tornvall P; Waeg G; Nilsson J; Hamsten A; Regnström J
    Atherosclerosis; 2003 Apr; 167(2):347-53. PubMed ID: 12818418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice.
    Tsimikas S; Palinski W; Witztum JL
    Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):95-100. PubMed ID: 11145939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease.
    Boullier A; Hamon M; Walters-Laporte E; Martin-Nizart F; Mackereel R; Fruchart JC; Bertrand M; Duriez P
    Clin Chim Acta; 1995 Jun; 238(1):1-10. PubMed ID: 7554289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-density lipoprotein oxidation is increased in kidney transplant recipients.
    van den Dorpel MA; Ghanem H; Rischen-Vos J; Man in 't Veld AJ; Jansen H; Weimar W
    Transpl Int; 1996; 9 Suppl 1():S54-7. PubMed ID: 8959791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease.
    Holvoet P; Perez G; Zhao Z; Brouwers E; Bernar H; Collen D
    J Clin Invest; 1995 Jun; 95(6):2611-9. PubMed ID: 7769103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.